FYERS
Alivus Life Sciences1370.00
-48.80 (-3.44%)

Alivus Life Sciences Share Price

1370.00-48.80 (-3.44%)
+46.16% past 1 Year

Shareholding summary

Promoters
74.87%
FII
5.54%
DII
1.53%
MF
5.65%
Others
12.41%
Promoters
FII
DII
MF
Others
Quarterly
Yearly

Shareholding Pattern

Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
74.87%74.87%74.91%74.91%74.94%74.99%
5.54%5.30%5.08%6.84%6.42%6.57%
1.53%1.64%1.69%1.60%1.56%1.60%
5.65%5.63%5.44%3.87%4.06%3.59%
12.41%12.56%12.88%12.78%13.02%13.25%

Bulk & block deals

Name
Icici Prudential Mutual Fund
Societe Generale
Bnp Paribas Arbitrage
Polar Capital Funds Plc-Healthcare Opportunities Fund
Nk Securities Research Private Limited
Nk Securities Research Private Limited
Deal DateActionDeal ValueDeal PriceQty TradedDeal Type%Stake TradedExchange
04 Dec 2025Purchase84.38 Cr₹8709.70 LBulk0.790015BSE
25 Jan 2024Purchase12.09 Cr₹799.551.51 LBlock0.123134BSE
25 Jan 2024Sell12.09 Cr₹799.551.51 LBlock0.123134BSE
09 Aug 2021Purchase61.24 Cr₹732.558.36 LBulk0.68094NSE
06 Aug 2021Purchase72.83 Cr₹765.779.51 LBulk0.774689NSE
06 Aug 2021Sell72.87 Cr₹766.129.51 LBulk0.774689NSE

Insider trading & SAST

Client name
Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd
Glenn Mario Saldanha
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Ltd
Nirma Ltd
Nirma Ltd
Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited
Reported onClient categoryAction%Stake tradedHolding % post dealDeal valueDeal priceQty tradedDeal periodDeal modePost transaction holdingInsider/SASTRegulation typeSecurity type
24 Dec 2024PromoterPledge20—0—2.45 Cr12 Mar 2024Release96,09,571SASTReg31—
22 Jul 2024PromoterDisposal7.84—0—96.10 L11 Jul 2024 - 12 Jul 2024Offer For Sale—SAST29(2)—
17 Jul 2024PromoterNon disposal undertaking——0—96.10 L04 Jul 2024Release0SASTReg31—
15 Jul 2024Promoter GroupDisposal0.006366064.71 L₹829.637.80 K11 Jul 2024 - 12 Jul 2024Others0Insider Trading—Equity Shares
15 Jul 2024PromoterDisposal7.8428060798.30 Cr₹830.7396.10 L11 Jul 2024 - 12 Jul 2024Others0Insider Trading—Equity Shares
19 Mar 2024PromoterDisposal207.840—2.45 Cr12 Mar 2024Off Market96,09,571SAST29(2)—
19 Mar 2024PromoterAcquisition20750—2.45 Cr12 Mar 2024Off Market9,18,96,285SAST29(2)—
14 Mar 2024PromoterAcquisition55550—6.74 Cr05 Mar 2024 - 06 Mar 2024Off Market6,73,90,850SAST29(1)—
14 Mar 2024PromoterDisposal5527.840—6.74 Cr06 Mar 2024Off Market3,41,15,006SAST29(2)—
13 Mar 2024PromoterDisposal19.9999967.841,465.40 Cr₹597.992.45 Cr12 Mar 2024Off Market96,09,571Insider Trading—Equity Shares

Alivus Life Sciences Ltd Share Price Today

The Alivus Life Sciences Ltd share price today is ₹1,418.50. During the trading session, the Alivus Life Sciences Ltd share price opened at ₹1,417.90 and recorded an intraday high of ₹1,439.40 and a low of ₹1,412.80. Last closing price was ₹1,417.90. Over the past 52 weeks, the Alivus Life Sciences Ltd share price has ranged between ₹819.00 and ₹1,493.80. The current Alivus Life Sciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.